- MS,
Venner PM,
Patterson AL,
Sarosdy MF,
Vogelzang NJ, Sc****enger JJ,
Kolvenbag GJ (September 1997). "Clinical
benefits of
bicalutamide compared with...
-
antiandrogen Discovery and
development of
antiandrogens Nonsteroidal estrogen Kolvenbag,
Geert J. C. M.; Furr,
Barrington J. A. (2009). "Nonsteroidal Antiandrogens"...
- pp. 325–346. doi:10.1007/978-1-59259-152-7_15. ISBN 978-1-60761-471-5.
Kolvenbag GJ, Furr BJ (2009). "Nonsteroidal Antiandrogens". In
Jordan VC, Furr BJ...
-
archived (PDF) from the
original on 24
October 2016,
retrieved 20 July 2016
Kolvenbag GJ,
Blackledge GR (January 1996). "Worldwide
activity and
safety of bicalutamide:...
- (1): 63–66. doi:10.1080/gye.16.1.63.66. PMID 11915584. S2CID 6942048.
Kolvenbag GJ, Furr BJ (2009). "Nonsteroidal Antiandrogens". In
Jordan VC, Furr VJ...
-
Testicular Toxicity ****essment. CRC Press. pp. 107–. ISBN 978-0-8493-5980-4.
Kolvenbag GJ,
Blackledge GR (January 1996). "Worldwide
activity and
safety of bicalutamide:...
-
Hormone analog for the
treatment of
advanced metastatic prostate carcinoma.
Kolvenbag GJ,
Blackledge GR (January 1996). "Worldwide
activity and
safety of bicalutamide:...
-
Hormone analog for the
treatment of
advanced metastatic prostate carcinoma.
Kolvenbag GJ,
Blackledge GR (January 1996). "Worldwide
activity and
safety of bicalutamide:...
-
Delaere KP,
Vaage S,
Tammela TL,
Lukkarinen O,
Persson BE,
Carroll K,
Kolvenbag GJ (August 2002). "Bicalutamide as
immediate therapy either alone or as...
- 13–25,
discussion 29–32. doi:10.1016/S0090-4295(96)80003-3. PMID 8560673.
Kolvenbag GJ, Furr BJ,
Blackledge GR (December 1998). "Receptor
affinity and potency...
